Cargando…

Prognostic potential of an immune score based on the density of CD8(+) T cells, CD20(+) B cells, and CD33(+)/p-STAT1(+) double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients

OBJECTIVE: There is heterogeneity in the prognosis of gastric cancers staged according to the tumornodes- metastasis (TNM) system. This study evaluated the prognostic potential of an immune score system to supplement the TNM staging system. METHODS: An immunohistochemical analysis was conducted to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jun, Li, Jiao, Liu, Shiming, Feng, Xingyu, Chen, Shi, Zhou, Zhiwei, Chen, Yingbo, Zhang, Xiaoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101229/ https://www.ncbi.nlm.nih.gov/pubmed/27877014 http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.10

Ejemplares similares

CD33(+)/p-STAT1(+) double-positive cell as a prognostic factor for stage IIIa gastric cancer
por: Dong, Jun, et al.
Publicado: (2013)

Decreased Levels of STAT1 and Interferon‐γ–Induced STAT1 Phosphorylation in Rheumatoid Arthritis CD4 and CD8 T Cells
por: Sharma, Vishal, et al.
Publicado: (2021)

Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2019)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
por: Gao, Qun, et al.
Publicado: (2019)

HMGB1 Recruits TET2/AID/TDG to Induce DNA Demethylation in STAT3 Promoter in CD4(+) T Cells from aGVHD Patients
por: Xu, Xuejun, et al.
Publicado: (2020)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

STAT5 and CD4 (+) T Cell Immunity
por: Owen, David L., et al.
Publicado: (2017)

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
por: Ehninger, A, et al.
Publicado: (2014)

CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
por: Stanchina, Michele, et al.
Publicado: (2019)

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
por: Roskopf, Claudia C., et al.
Publicado: (2016)

Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2020)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

STAT3 mediates resistance of CD44(+)CD24(−/low) breast cancer stem cells to tamoxifen in vitro
por: Wang, Xiaoyan, et al.
Publicado: (2012)

Impaired Development of CD4(+) CD25(+) Regulatory T Cells in the Absence of STAT1: Increased Susceptibility to Autoimmune Disease
por: Nishibori, Takeaki, et al.
Publicado: (2004)

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
por: Shinoda, Koji, et al.
Publicado: (2023)

CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer
por: Mao, Fang-yuan, et al.
Publicado: (2018)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c(+) Conventional Dendritic Cell Subsets Mediated by CD103 and CD205
por: Lu, Yong, et al.
Publicado: (2019)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
por: Son, Myoungsun, et al.
Publicado: (2017)

CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation
por: Shen, Yao-An, et al.
Publicado: (2016)

TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes
por: Iriani, Anggraini, et al.
Publicado: (2023)

STAT3 regulates CD8(+) T cell differentiation and functions in cancer and acute infection
por: Sun, Qinli, et al.
Publicado: (2023)

Activation of naïve CD4(+) T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4(+) T cells
por: Twohig, Jason P., et al.
Publicado: (2019)

CD8(+)CD57(+) T cells exhibit distinct features in human non-small cell lung cancer
por: Huang, Bing, et al.
Publicado: (2020)

Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: Han, Jingqi, et al.
Publicado: (2022)

HMGB2 regulates the differentiation and stemness of exhausted CD8(+) T cells during chronic viral infection and cancer
por: Neubert, Emily N., et al.
Publicado: (2023)

CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer
por: Tallón de Lara, Paulino, et al.
Publicado: (2021)

IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing
por: Andreone, Sara, et al.
Publicado: (2019)

Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer
por: Chen, Min, et al.
Publicado: (2021)

Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
por: Zhou, Jian, et al.
Publicado: (2020)

BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer
por: Feng, Mei, et al.
Publicado: (2021)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

Differentiation-Associated MicroRNA Alterations in Mouse Heart-Derived Sca-1(+)CD31(−) and Sca-1(+)CD31(+) Cells
por: Wu, Qiong, et al.
Publicado: (2016)

IL-33 Effect on Quantitative Changes of CD4(+)CD25(high)FOXP3(+) Regulatory T Cells in Children with Type 1 Diabetes
por: Ryba-Stanisławowska, Monika, et al.
Publicado: (2016)

Low CD8(+) T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44(+)/CD133(+) Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
por: Hou, Ya-Chin, et al.
Publicado: (2019)

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)CD43(+)CD70(−)
por: Griffin, Daniel O., et al.
Publicado: (2011)

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)CD43(+)CD70(−)
por: Griffin, Daniel O., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n5qolv5torbev4sjjl2ai7q3lh